Description
The Celsis Advance II instrument provides a high-throughput ATP bioluminescence rapid microbiology detection solution that has helped companies worldwide screen products for microbial contamination. With installations in more than 65 countries and a global network of service and support partners, Celsis® is uniquely positioned to work with organizations of all sizes looking to reduce the delays and associated costs of lengthy micro hold times. The user-friendly workflow of the Celsis Advance II minimizes the need for changes to existing test methods, while its objective, automated analysis and reporting capabilities enhance data integrity. This compact and cost-effective instrument delivers definitive micro results quickly, enabling sterile and non-sterile drug manufacturers to cut days off their production cycles and reduce working capital requirements. The Celsis Advance II offers an exceptionally high throughput of up to 120 assays per hour, supporting large-scale manufacturing operations by delivering results in less than 48 hours for microbial limits (USP <61>) and 6 days for sterility testing (USP <71>).